These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1974412)
1. Leucopenia after gold and sulphasalazine treatment. Schmidt KL Ann Rheum Dis; 1990 Jun; 49(6):422. PubMed ID: 1974412 [No Abstract] [Full Text] [Related]
2. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment. Bliddal H; Eiberg B; Helin P; Svejgaard A Ann Rheum Dis; 1989 Jul; 48(7):539-41. PubMed ID: 2570550 [TBL] [Abstract][Full Text] [Related]
3. Gold-induced leucopenia may predict a similar adverse reaction to sulphasalazine. Bliddal H; Eiberg B; Helin P Lancet; 1987 Feb; 1(8529):390. PubMed ID: 2880198 [No Abstract] [Full Text] [Related]
4. Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy. Amos RS; Bax DE Br J Rheumatol; 1988 Dec; 27(6):465-8. PubMed ID: 2904830 [TBL] [Abstract][Full Text] [Related]
5. Leucopenia during sulphasalazine treatment for rheumatoid arthritis. Marabani M; Madhok R; Capell HA; Hunter JA Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110 [TBL] [Abstract][Full Text] [Related]
6. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Pullar T; Hunter JA; Capell HA Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117 [TBL] [Abstract][Full Text] [Related]
7. Leucopenia, thrombocytopenia and lymphadenopathy associated with sulphasalazine. McKenna KE; Burrows D Clin Exp Dermatol; 1994 Sep; 19(5):419-20. PubMed ID: 7955504 [TBL] [Abstract][Full Text] [Related]
8. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone. Grindulis KA; McConkey B Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295 [TBL] [Abstract][Full Text] [Related]
9. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis. Williams HJ J Rheumatol Suppl; 1988 Sep; 16():9-13. PubMed ID: 2903928 [TBL] [Abstract][Full Text] [Related]
10. HLA DR antigens and gold toxicity. Gran JT; Husby G; Thorsby E Ann Rheum Dis; 1983 Feb; 42(1):63-6. PubMed ID: 6402993 [TBL] [Abstract][Full Text] [Related]
11. [Fatal aplastic anemia]. Skotte T Tidsskr Nor Laegeforen; 1979 May; 99(13):632. PubMed ID: 36685 [No Abstract] [Full Text] [Related]
12. [Sulfasalazine in the treatment of chronic juvenile arthritis]. Hoza J; Havelka S; Kadlecová T; Nĕmcová D Cesk Pediatr; 1989 Oct; 44(10):601-3. PubMed ID: 2575932 [TBL] [Abstract][Full Text] [Related]
13. Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine. Bliddal H; Helin P Clin Rheumatol; 1987 Jun; 6(2):244-50. PubMed ID: 2887331 [TBL] [Abstract][Full Text] [Related]
14. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease. Capell HA; Pullar T; Hunter JA Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852 [TBL] [Abstract][Full Text] [Related]
15. A multicentre pilot study of sulphasalazine in juvenile chronic arthritis. Ansell BM; Hall MA; Loftus JK; Woo P; Neumann V; Harvey A; Sills JA; Swinson D; Insley J; Amos R Clin Exp Rheumatol; 1991; 9(2):201-3. PubMed ID: 1676352 [TBL] [Abstract][Full Text] [Related]